Pharmacoeconomic analysis of antibacterial medicines used in dentistry
DOI:
https://doi.org/10.24959/cphj.14.1293Keywords:
pharmacoeconomic analysis, synthetic and natural dental medicinesAbstract
This article presents data on pharmacoeconomic analysis of 15 antimicrobial medicines, which are used in dentistry. In order to conduct this analysis the method of estimation of drug antimicrobial properties has been suggested and applied; it is based on vector algebra that allowed calculating a complex indicator of the drug antimicrobial activity for quantitative estimation of the pharmacological effect. It has been shown that the tincture of Sophora japonica and the solution of chlorhexidine digluconate have the best indicators of antimicrobial properties and the lowest treatment cost among the medicines studied at the level of 5-10 UAH. The second group of medicines – “Sanguiritrin” and “Chlorophillipt” (Galichpharm) – is as good as the first one in terms of antimicrobial properties, but the course of treatment with these medicines costs up to 30-40 UAH. The third group of medicines – “Metrogyl Denta”, the tincture of eucalyptus – exhibits antimicrobial properties of a medium potency and their cost for the treatment course is in the range of 10-20 UAH. The forth group of medicines – “Rotokan”, “Romazulan”, the tincture of calendula and the tincture of propolis – exhibits the weak antimicrobial properties and has a relatively low cost of treatment in the range of 5-20 UAH. The fifth group of medicines – “Stomatofit”, “Orasept”, “Hexoral”, “Fitodent”, and “Kamistad” – exhibits the weakest antimicrobial properties and has the most expensive course of treatment in the range of 40-80 UAH. It has been noted that some of the medicines studied have impractical volume since up to half of the pack is left after finishing the course of treatment. Therefore, we can recommend manufacturers to reduce the drug quantity in the pack by 30-50% for consumer’s convenience.
References
Волянський Ю.Л., Гриценко І.С., Широкобоков В.П. та ін. Вивчення специфічної активності антимікробних лікарських засобів: Метод. рекоменд. – К., 2004. – 38 с.
Волянський Ю.Л., Бірюкова С.В., Гриценко І.С. та ін. Вивчення специфічної активності антимікробних лікарських засобів. – Х., 2004. – 38 с.
Державна фармакопея України / Державне підприємство «Науково-експертний фармакопейний центр». – 1-е вид. – Х.: РІРЕГ, 2001. – Доп. 1. – 2004. – 520 с.
Компендиум 2005 – лекарственные препараты / Под ред. В.Н.Коваленко, А.П.Викторова. – К.: МОРИОН, 2005. – 1920 с.
Основные методы лабораторных исследований в клинической бактериологии / Под ред. ВОЗ. – Женева, 1994. – 131 с.
Albandar J.M., Rams T.E. // Periodontol. 2000. – 2002. – Vol. 29. – P. 7-10.
Axelsson P., Albandar J.M., Rams T.E. // Periodontol. 2000. – 2002. – Vol. 29. – P. 235-246.
Bascones Martinez A., Figuero Ruiz E. // Av. Periodontol. Implantol. – 2005. – Vol. 17, №3. – P. 111-118.
Cobb Charles M. // The J. of Dental Hygiene. – 2008. – Vol. 83, №6. – P. 4-9.
John G. Meechan, Robin Seymour Drug Dictionary for Dentistry. 1-st ed. – Publisher: Oxford University Press, USA. 2002. – 444 p.
Nishihara T., T. Koseki // Periodontol. 2000. – 2004. – №36. – P. 14-26.
Position Paper Guidelines for Periodontal Therapy // J. of Periodontol. – 2001. – Vol. 72, №11. – P. 1624-1628.
Quirynen M., Teughels W., De Soete M., van Steenberghe D. // Periodontol. 2000. – 2002. – Vol. 28. – P. 72-90.
Slots J. // J. Periodontal Res. – 2002. – Vol. 37. – P. 389-398.
Slots J., Jorgensen M.G. // Periodontol. 2000. – 2002. – Vol. 28. – P. 298-312.
Walker C.B., Karpinia K., Baehli P. // Periodontol. 2000. – 2004. – Vol. 36. – P. 146-165.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
